Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07104279 · ClinicalTrials.gov registry record

Z1 Hip System: Post-Market Clinical Follow Up Study

A clinical trial of Hip Osteoarthritis and Avascular Necrosis of the Femoral Head, sponsored by Zimmer Biomet.

Recruiting
Registry status
150
Enrollment target
2
Study locations

NCT07104279 is a study of Hip Osteoarthritis and Avascular Necrosis of the Femoral Head that is actively recruiting participants, run by Zimmer Biomet. The registered enrollment target is 150 participants, below the 391-participant average among 11 other Hip Osteoarthritis trials with a reported enrollment target (62% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07104279, a study of Hip Osteoarthritis and Avascular Necrosis of the Femoral Head, is actively recruiting participants, sponsored by Zimmer Biomet.

RECRUITING
Registry status
150 participants
Enrollment target
2
Study locations

Study Summary

The objectives of this study are to confirm the early to mid-term safety, performance, and clinical benefits of the Z1 Femoral Hip System in hemi-hip arthroplasty and primary total hip arthroplasty. The primary objective of this post market clinical follow-up (PMCF) study is the assessment of safety by recording and analyzing the survival of the implant system at 2 years post-implantation. Safety will also be established by recording the incidence and frequency of revisions, complications, and adverse events. Relation of the events to implant, instrumentation, and/or procedure should be specified. The secondary objective is the assessment of functional performance and clinical benefits of the Z1 Femoral Hip System demonstrated by recording patient-reported clinical outcomes measures (PROMs).

Conditions Studied

Hip Osteoarthritis Avascular Necrosis of the Femoral Head Acute Traumatic Fracture of the Femoral Head or Neck

Interventions

  • DEVICE Z1 Femoral Hip System

Study Locations (2)

North Carolina

  • OrthoCarolina/OrthoCarolina Research Institute - Charlotte

Oregon

  • Orthopedic & Fracture Specialists - Portland

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2025-10-13
Est. Completion 2031-08

Sponsor

Zimmer Biomet

115 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07104279

The ClinicalTrials.gov registry entry for NCT07104279 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 391-participant average among 11 other Hip Osteoarthritis trials with a reported enrollment target (62% lower). The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Hip Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which Z1 Femoral Hip System is the first listed.

NCT07104279 reports 2 study locations spanning 2 distinct geographic areas - top geographies include North Carolina, Oregon.

Frequently Asked Questions

What is clinical trial NCT07104279 about?

NCT07104279 is a clinical study titled "Z1 Hip System: Post-Market Clinical Follow Up Study". The objectives of this study are to confirm the early to mid-term safety, performance, and clinical benefits of the Z1 Femoral Hip System in hemi-hip arthroplasty and primary total hip arthroplasty. The primary objective of this post market clinical follow-up (PMCF) study is the assessment of safet...

What is the current status of trial NCT07104279?

This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2025-10-13. Estimated completion is 2031-08.

What conditions does trial NCT07104279 study?

This clinical trial studies the following conditions: Hip Osteoarthritis, Avascular Necrosis of the Femoral Head, Acute Traumatic Fracture of the Femoral Head or Neck.

What interventions are being tested in trial NCT07104279?

The interventions under investigation include: Z1 Femoral Hip System (DEVICE).

Who is sponsoring clinical trial NCT07104279?

This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07104279 being conducted?

This trial has 2 study locations across North Carolina, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hip Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hip Osteoarthritis

All registered trials for this condition

Avascular Necrosis of the Femoral Head

All registered trials for this condition

North Carolina

All trials with a study site in North Carolina

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.